GI
Gavea Investimentos Portfolio holdings
AUM
$77.6M
This Quarter Return
+14.59%
1 Year Return
-63.39%
3 Year Return
-62.15%
5 Year Return
–
10 Year Return
–
AUM
$55.5M
AUM Growth
+$55.5M
(+33%)
Cap. Flow
+$1.9M
Cap. Flow
% of AUM
3.43%
Top 10 Holdings %
Top 10 Hldgs %
94.02%
Holding
22
New
9
Increased
1
Reduced
2
Closed
4
Top Buys
| 1 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
$10M |
| 2 |
Northrop Grumman
NOC
|
$6.4M |
| 3 |
Quest Diagnostics
DGX
|
$5.67M |
| 4 |
Johnson & Johnson
JNJ
|
$4.72M |
| 5 |
Kroger
KR
|
$3.27M |
Top Sells
| 1 |
Vale
VALE
|
$20.3M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
$6.23M |
| 3 |
Pfizer
PFE
|
$5.59M |
| 4 |
Elevance Health
ELV
|
$2.69M |
| 5 |
Altria Group
MO
|
$2.32M |
Sector Composition
| 1 | Healthcare | 27.03% |
| 2 | Communication Services | 26.35% |
| 3 | Materials | 11.98% |
| 4 | Industrials | 11.53% |
| 5 | Consumer Staples | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
1
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $10M | 16.78% | +143,736 | New | +$10M |
|
|
2
Vale
VALE
$43.9B
| $6.65M | 11.16% | 396,895 -1,212,341 | -75% | -$20.3M |
|
|
3
Northrop Grumman
NOC
$84.5B
| $6.4M | 10.74% | +20,998 | New | +$6.4M |
|
|
4
Quest Diagnostics
DGX
$20.3B
| $5.67M | 9.52% | +47,594 | New | +$5.67M |
|
5
Petrobras
PBR
$79.9B
| $5.32M | 8.93% | 473,977 +30,670 | +7% | +$344K |
|
|
6
Johnson & Johnson
JNJ
$427B
| $4.72M | 7.92% | +30,000 | New | +$4.72M |
|
7
Meta Platforms (Facebook)
META
$1.86T
| $4.63M | 7.76% | 16,935 -784 | -4% | -$214K |
|
|
8
Kroger
KR
$44.9B
| $3.27M | 5.48% | +102,864 | New | +$3.27M |
|
9
Walmart
WMT
$774B
| $3.06M | 5.14% | +21,242 | New | +$3.06M |
|
10
Centene
CNC
$14.3B
| $2.47M | 4.14% | +41,142 | New | +$2.47M |
|
11
Cigna
CI
$80.3B
| $2.14M | 3.59% | +10,290 | New | +$2.14M |
|
12
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$583M
| $1.18M | 1.97% | +70,000 | New | +$1.18M |
|
13
AstraZeneca
AZN
$248B
| – | – | 0 | – | – |
|
14
Bank of America
BAC
$376B
| – | – | 0 | – | – |
|
|
15
Elevance Health
ELV
$71.8B
| – | – | -10,000 | Closed | -$2.69M |
|
16
JPMorgan Chase
JPM
$829B
| – | – | 0 | – | – |
|
17
Mercado Libre
MELI
$125B
| – | – | 0 | – | – |
|
|
18
Altria Group
MO
$113B
| – | – | -60,045 | Closed | -$2.32M |
|
19
iShares S&P 100 ETF
OEF
$22B
| – | – | 0 | – | – |
|
|
20
Pfizer
PFE
$141B
| – | – | -152,208 | Closed | -$5.59M |
|
21
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
22
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$262M
| – | – | -250,000 | Closed | -$6.23M |
|